Evaluate the Association Between Infection and Thrombocytopenia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

390 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed to evaluate the association between nosocomial bloodstream infection and the occurrence of thrombocytopenia in surgical critical ill patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients

NCT05958511

Thrombocytopenia

UNKNOWN

Inflammatory Anemia Associated Parameters in Septic Patients

NCT04281888

Inflammatory Response

UNKNOWN

Hemostatic Disorders on Intensive Care Patients.

NCT04179357

Hemostatic Disorder

UNKNOWN

Indicators of Inflammation and Coagulation in Sepsis

NCT01128283

Sepsis

COMPLETED

ICU Venous Thromboembolism Incidence Study in a Chinese Population

NCT01504087

Venous Thromboembolism

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thrombocytopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BSI group with thrombocytopenia

BSI patients with thrombocytopenia

No interventions assigned to this group

Non-BSI group with thrombocytopenia

Non-BSI patients with thrombocytopenia

No interventions assigned to this group

BSI group without thrombocytopenia

BSI patients without thrombocytopenia

No interventions assigned to this group

Non-BSI group without thrombocytopenia

Non-BSI patients without thrombocytopenia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sequential consenting adult patients of either sex were prospectively enrolled into the study.

Exclusion Criteria

* Patients who passed away within 24 hours after hospitalization would be excluded.

Patients who developed into a bloodstream infection within 48 hours after hospital admission were also excluded.

Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No